More Botanix Pharmaceuticals Limited news
Botanix Pharmaceuticals LimitedASX: BOT

S&P DJI Announces March 2024 Quarterly Rebalance

Mar 1, 2024 at 6:24 AM EST · Issued by Botanix Pharmaceuticals Limited

Filed with ASX · Mar 1, 2024 at 6:24 AM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2024-quarterly-rebalance-47

Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2↗

Botanix Pharmaceuticals Limited on 6ix

Earlier from Botanix Pharmaceuticals

  • Botanix Pharmaceuticals Half Year ReportFeb 27, 2024
  • December 2023 Quarterly Activities Report and Appendix 4CJan 30, 2024
  • NDA Resubmission Accepted and Approval Date ConfirmedJan 21, 2024
  • Botanix Resubmission of NDA for Sofdra CompletedDec 20, 2023
  • Successful Completion of Human Factors StudyDec 13, 2023

Later from Botanix Pharmaceuticals

  • March 2024 Quarterly Activities Report and Appendix 4CApr 30, 2024
  • Final Sofdra Labelling Discussions with FDAJun 11, 2024
  • FDA Approves SofdraJun 19, 2024
  • Botanix $70 Million Institutional Capital RaisingJun 21, 2024
  • June 2024 Quarterly Activities Report and Appendix 4CJul 30, 2024
All Botanix Pharmaceuticals news releases↗

Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.

Follow Botanix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer